To elucidate the role of tumor necrosis factor receptor superfamily member 14 (TNFRSF14) in metabolic disturbance due to loss of ovarian function, ovariectomy (OVX) was performed in TNFRSF 14-knockout mice. OVX increased fat mass and infiltration of highly inflammatory CD11c cells in the adipose tissue (AT), which was analyzed by flow cytometry, and resulted in disturbance of glucose metabolism, whereas TNFRSF14 deficiency attenuated these effects. TNFRSF14 deficiency decreased recruitment of CD11c-expressing cells in AT and reduced the polarization of bone marrow-derived macrophages to M1. Upon engagement of LIGHT, a TNFRSF14 ligand, TNFRSF14 enhanced the expression of CD11c via generation of reactive oxygen species, suggesting a role of TNFRSF14 as a redox modulator. TNFRSF14 participated in OVX-induced AT inflammation via upregulation of CD11c, resulting in metabolic perturbation. TNFRSF14 could be used as a therapeutic target for the treatment of postmenopausal syndrome by reducing AT inflammation. © 2014 Society for Endocrinology Printed in Great Britain Published by Bioscientifica Ltd.
CITATION STYLE
Choi, E. K., Kim, W. K., Sul, O. J., Park, Y. K., Kim, E. S., Suh, J. H., … Choi, H. S. (2014). TNFRSF14 deficiency protects against ovariectomy-induced adipose tissue inflammation. Journal of Endocrinology, 220(1), 25–33. https://doi.org/10.1530/JOE-13-0341
Mendeley helps you to discover research relevant for your work.